Skip to content

Dutch study finds out whether gay men prefer daily or on-demand PrEP

Hanne Zimmermann presenting at IAS 2017. Image credit: Ejay de Wit (@ejaydewit)

Doravirine combination pill looks good for initial HIV treatment

Kathleen Squires at IAS 2017. Photo by Liz Highleyman, hivandhepatitis.com

Acute kidney injury ‘uncommon’ but unpredictable on tenofovir and ritonavir

Acute kidney injury ‘uncommon’ but unpredictable on tenofovir and ritonavir

Integrase inhibitors not causing higher rates of adverse birth outcomes, Botswana and French studies show

Rebecca Zash at IAS 2017. Photo by Steve Forrest/Workers' Photos/IAS

New guidance says start HIV treatment within 7 days of diagnosis – but is everyone ready?

Presentation by Brendan Maughan-Brown at IAS 2017. www.ias2017.org

International study of gay couples reports no transmissions from an HIV-positive partner on treatment

Image from Opposites Attract study: www.oppositesattract.net.au

New integrase inhibitor bictegravir works well for first-line HIV treatment

Joel Gallant presents new data on bictegravir at IAS2017. Photo by Liz Highleyman, hivandhepatitis.com

Less frequent clinic visits for HIV care: fine tuning needed

MSF Community Adherence Club KwaZulu-Natal. Photo by Greg Lomas / Scholars and Gentlemen / Médecins sans Frontières

Swaziland: new infections halved in five years as HIV treatment scales up

Velephi Okello at IAS 2017. Photo by Liz Highleyman, hivandhepatitis.com